首页> 外国专利> DEPRESSIVE OR EPILEPTIC ANIMAL MODEL, ESTABLISHMENT METHOD THEREFOR, AND METHOD FOR SCREENING CANDIDATE DRUG FOR THERAPY OF DEPRESSIVE DISORDER OR EPILEPSY USING SAME

DEPRESSIVE OR EPILEPTIC ANIMAL MODEL, ESTABLISHMENT METHOD THEREFOR, AND METHOD FOR SCREENING CANDIDATE DRUG FOR THERAPY OF DEPRESSIVE DISORDER OR EPILEPSY USING SAME

机译:抑郁或癫痫动物模型,其建立方法以及使用相同方法治疗抑郁症或癫痫的候选药物筛选方法

摘要

The present invention relates to a depressive or epileptic animal model and an establishment method therefor using CRISPR/Cas9 molecular scissors technology and further to a method for screening a candidate drug for therapy of depressive disorder or epilepsy using the animal model. Lacking most of the Kcnk1 gene, in contrast to the mice from which the Kcnk1 gene is partially deleted by classical genetic recombination techniques, Kcnk1 gene-knockout mice established using CRISPR/Cas9 molecular scissors according to the present invention show intrinsic symptoms of depressive disorder and/or epilepsy with the onset of depressive disorder and/or epilepsy therein and are expected to be useful as an animal model for research on the progression and pathological mechanism of depressive disorder and/or epilepsy. In addition, it is expected that the Kcnk1-knockout mice according to the present invention are effectively used for screening candidate drugs for prophylaxis or therapy of depressive disorder and/or epilepsy.
机译:本发明涉及使用CRISPR / Cas9分子剪刀技术的抑郁或癫痫动物模型及其建立方法,还涉及使用该动物模型筛选用于治疗抑郁症或癫痫的候选药物的方法。与通过经典的基因重组技术将Kcnk1基因部分缺失的小鼠相比,大多数Kcnk1基因缺乏,使用本发明的CRISPR / Cas9分子剪刀建立的Kcnk1基因敲除小鼠表现出抑郁症的内在症状,并且和/或其中伴有抑郁症和/或癫痫发作的癫痫病,并且有望用作研究抑郁症和/或癫痫病的进展和病理机制的动物模型。另外,预期根据本发明的Kcnk1-敲除小鼠可有效地用于筛选用于预防或治疗抑郁症和/或癫痫的候选药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号